North America
Vetter Breaks Ground on New Clinical Manufacturing Site in Illinois to Expand U.S. Operations
Production site expected to be fully operational by the end of 2029 Modern site with holistic approach for state-of-the-art manufacturing operations Fu...
June 30, 2025 | News
ProBio Opens 128,000 sq ft Cell and Gene Therapy Center of Excellence in New Jersey to Accelerate Advanced Biomanufacturing
ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flags...
June 30, 2025 | News
Invetech and AiCella Forge Strategic Alliance to Advance AI-Driven Cell Therapy Manufacturing
Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today anno...
June 27, 2025 | News
LTS and Nualtis Forge Strategic Alliance to Scale Oral Thin Film Drug Manufacturing Globally
LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film ...
June 26, 2025 | News
Xcell Biosciences and Thermo Fisher Scientific Unite to Advance Treg and TIL Cell Therapies for Autoimmune and Solid Tumor Diseases
Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic coll...
June 25, 2025 | News
Sartorius Launches Inaugural PI Forum to Accelerate the Future of Biomanufacturing
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, is proud to launch the Sartorius PI Forum, taking p...
June 25, 2025 | News
Formation Bio Licenses Gusacitinib to Sanofi in Deal Worth Up to €545 Million
Deal could be worth up to €545 million, including upfront and milestone payments, as well as low to mid-teen royalties based on ...
June 24, 2025 | News
Daiichi Sankyo and AstraZeneca’s DATROWAY Receives U.S. FDA Accelerated Approval for EGFR-Mutated Lung Cancer
Based on TROPION-Lung05 phase 2 trial results and supported by data from the TROPION-Lung01 phase 3 trial Second U.S. approval for Daiichi Sankyo and ...
June 24, 2025 | News
Harbour BioMed and Otsuka Ink $670M+ Global Deal to Advance Bispecific T-Cell Engager for Autoimmune Diseases
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology,&nb...
June 23, 2025 | News
XtalPi and DoveTree Sign $100M+ LOI to Accelerate AI-Driven Drug Discovery Across Oncology and Neurology
XtalPi, a global leader in AI- and robotics-powered drug and materials discovery, announced it has signed a Letter of Intent (LOI) with DoveTre...
June 23, 2025 | News
Simcere Zaiming Doses First U.S. Patient in Phase 1 Trial of Trispecific Antibody SIM0500 for Relapsed/Refractory Multiple Myeloma
Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group announced the first US patient has started treatment in the ongo...
June 19, 2025 | News
Veranova Invests Over $50M to Launch Bioconjugation Development and GMP Manufacturing in Massachusetts
Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pha...
June 19, 2025 | News
Abu Dhabi Department of Health and Boehringer Ingelheim Forge Strategic Partnership to Advance Life Sciences and Innovation at BIO 2025
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU)...
June 17, 2025 | News
Thermo Fisher’s Integrated CDMO-CRO Model Cuts Drug Development Time by Up to 34 Months, Finds Tufts CSDD Study
Thermo Fisher Scientific Inc., the world leader in serving science, announced the findings of new research by the Tufts Center for the Study of Drug ...
June 17, 2025 | News
Most Read
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
